Molecular determinants of response to high-dose daunorubicin induction chemotherapy

Main Navigation
Account Navigation
Main Content

JavaScript is disabled on your browser

Please enable JavaScript or upgrade to a JavaScript-capable browser to use the ASH Image Bank.

COLLECTION

Images of peripheral blood and/or bone marrow of blood disorders and normal hematopoiesis.
ATLAS

Normal and abnormal blood cells
REFERENCE CASES

Complete cases of common blood disorders (peripheral blood, bone marrow, and diagnostic studies).
UPLOAD IMAGES

Home / Collection

< Continue browsing

Molecular determinants of response to high-dose daunorubicin induction chemotherapy

#00017950

Author: Jay P. Patel and Ross L. Levine
Category: Myeloid Neoplasms and acute leukemia (WHO 2016) > Acute Myeloid Leukemia
Published Date: 04/18/2013

Molecular determinants of response to high-dose daunorubicin induction chemotherapy. Benefit of high-dose versus standard-dose daunorubicin in patients with NPM1/DNMT3A mutations or with MLL translocations compared with those wild-type for all 3 AML disease alleles is shown

Download Image